Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AIM
AIM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AIM News
AIM ImmunoTech Launches DURIPANC Clinical Trial for Pancreatic Cancer
2d ago
Newsfilter
AIM ImmunoTech Regains NYSE Compliance
4d ago
NASDAQ.COM
AIM ImmunoTech Secures $2.65 Million Financing
Jun 09 2026
seekingalpha
AIM ImmunoTech Announces $2.65 Million Financing
Jun 09 2026
Newsfilter
AIM ImmunoTech Reports Positive Clinical Progress in Pancreatic Cancer Study
Jun 08 2026
Newsfilter
Aimia Receives Approval for 5 Million Share Buyback
Jun 04 2026
Yahoo Finance
AIM ImmunoTech Hits Key Enrollment Milestone in Pancreatic Cancer Trial
Jun 01 2026
stocktwits
Aimia Inc. Repurchases 224,400 Common Shares in May 2026
Jun 01 2026
Yahoo Finance
AIM ImmunoTech to Release Ebola Drug Research Video Presentation
May 28 2026
NASDAQ.COM
AIM ImmunoTech Announces Direct Offering of Shares
May 21 2026
NASDAQ.COM
AIM ImmunoTech Announces Registered Direct Offering of Common Stock
May 20 2026
Newsfilter
AIM ImmunoTech's Financing Plan Triggers Stock Price Plunge
May 08 2026
stocktwits
Analysis of High Growth Tech Stocks in Australia
Apr 19 2026
Yahoo Finance
AIM ImmunoTech Reports Going Concern Emphasis in Financial Statements
Apr 13 2026
Newsfilter
AIM ImmunoTech Shares Surge 80% After Japanese Patent Approval
Mar 18 2026
NASDAQ.COM
AIM ImmunoTech Secures Japanese Patent Approval
Mar 18 2026
stocktwits
Show More News
